These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 15243145)
1. Informed consent for thrombolytic therapy for patients with acute ischemic stroke treated in routine clinical practice. Rosenbaum JR; Bravata DM; Concato J; Brass LM; Kim N; Fried TR Stroke; 2004 Sep; 35(9):e353-5. PubMed ID: 15243145 [TBL] [Abstract][Full Text] [Related]
2. Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire. Weintraub MI Stroke; 2006 Jul; 37(7):1917-22. PubMed ID: 16728683 [TBL] [Abstract][Full Text] [Related]
3. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group. Heuschmann PU; Berger K; Misselwitz B; Hermanek P; Leffmann C; Adelmann M; Buecker-Nott HJ; Rother J; Neundoerfer B; Kolominsky-Rabas PL; ; Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12663875 [TBL] [Abstract][Full Text] [Related]
4. Acute stroke management in the elderly. Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089 [TBL] [Abstract][Full Text] [Related]
6. The use and misuse of thrombolytic therapy within the Veterans Health Administration. Keyhani S; Arling G; Williams LS; Ross JS; Ordin DL; Myers J; Tyndall G; Vogel B; Bravata DM Med Care; 2012 Jan; 50(1):66-73. PubMed ID: 22182924 [TBL] [Abstract][Full Text] [Related]
7. Documentation of decision-making capacity, informed consent, and health care proxies: a study of surrogate consent. Glezer A; Stern TA; Mort EA; Atamian S; Abrams JL; Brendel RW Psychosomatics; 2011; 52(6):521-9. PubMed ID: 22054621 [TBL] [Abstract][Full Text] [Related]
9. Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke. Lin CB; Cox M; Olson DM; Britz GW; Constable M; Fonarow GC; Schwamm L; Peterson ED; Shah BR J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26201547 [TBL] [Abstract][Full Text] [Related]
10. Code stroke: a mismatch between number of activation and number of thrombolysis. Sung SF; Tseng MC J Formos Med Assoc; 2014 Jul; 113(7):442-6. PubMed ID: 24961186 [TBL] [Abstract][Full Text] [Related]
11. Changes in Informed Consent Policy and Treatment Delays in Stroke Thrombolysis. Xu H; De Silva DA; Woon FP; Ong MEH; Matchar DB; Bettger JP; Laskowitz DT; Xian Y J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105551. PubMed ID: 33348248 [TBL] [Abstract][Full Text] [Related]
12. Informed Consent for Intravenous Tissue Plasminogen Activator in New York State Designated Stroke Centers. Weintraub MI; Colello AD; Johnson SA; McClellan F; Cole SP; Benesch C; Rudolph SH; Levine SR J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1274-1279. PubMed ID: 28189569 [TBL] [Abstract][Full Text] [Related]
13. Urgent carotid intervention is safe after thrombolysis for minor to moderate acute ischemic stroke. Bazan HA; Zea N; Jennings B; Smith TA; Vidal G; Sternbergh WC J Vasc Surg; 2015 Dec; 62(6):1529-38. PubMed ID: 26412434 [TBL] [Abstract][Full Text] [Related]
14. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. Heuschmann PU; Kolominsky-Rabas PL; Roether J; Misselwitz B; Lowitzsch K; Heidrich J; Hermanek P; Leffmann C; Sitzer M; Biegler M; Buecker-Nott HJ; Berger K; JAMA; 2004 Oct; 292(15):1831-8. PubMed ID: 15494580 [TBL] [Abstract][Full Text] [Related]
15. The totaled health risks in vascular events (THRIVE) score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA trial. Kamel H; Patel N; Rao VA; Cullen SP; Faigeles BS; Smith WS; Flint AC J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1111-6. PubMed ID: 23122722 [TBL] [Abstract][Full Text] [Related]
16. Patient-Centered Decision Support in Acute Ischemic Stroke: Qualitative Study of Patients' and Providers' Perspectives. Decker C; Chhatriwalla E; Gialde E; Garavalia B; Summers D; Quinlan ME; Cheng E; Rymer M; Saver JL; Chen E; Kent DM; Spertus JA Circ Cardiovasc Qual Outcomes; 2015 Oct; 8(6 Suppl 3):S109-16. PubMed ID: 26515198 [TBL] [Abstract][Full Text] [Related]
17. The Role of Informed Consent for Thrombolysis in Acute Ischemic Stroke. Comer AR; Damush TM; Torke AM; Williams LS J Clin Ethics; 2019; 30(4):338-346. PubMed ID: 31851625 [TBL] [Abstract][Full Text] [Related]
18. Practice variation in the informed consent procedure for thrombolysis in acute ischemic stroke: a survey among neurologists and neurology residents. Zonjee VJ; Slenders JPL; de Beer F; Visser MC; Ter Meulen BC; Van den Berg-Vos RM; van Schaik SM BMC Med Ethics; 2021 Aug; 22(1):114. PubMed ID: 34433444 [TBL] [Abstract][Full Text] [Related]
19. Why are eligible thrombolysis candidates left untreated? Hills NK; Johnston SC Am J Prev Med; 2006 Dec; 31(6 Suppl 2):S210-6. PubMed ID: 17178305 [TBL] [Abstract][Full Text] [Related]
20. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke. Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]